Evidence map›Paper›PMID 18606837›Full record

ArticleAntimicrobial agents and chemotherapy2008

Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys.

Alexandra Vallon-Eberhard, Arik Makovitzki, Anne Beauvais, Jean-Paul Latgé, Steffen Jung, Yechiel Shai

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Synthesis and Biological Activity of Ultrashort Antimicrobial Peptides Bearing a Non-Coded Amino Acid.Journal of peptide science : an official publication of the European Peptide Society · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Antibacterial Activities of Lipopeptide (CInternational journal of molecular sciences · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. The potential of antimicrobial peptides as biocides.International journal of molecular sciences · 2011
    Review
  15. Review
  16. Article
  17. Article
  18. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  19. De novo designed synthetic mimics of antimicrobial peptides.Current opinion in biotechnology · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Alexandra Vallon-EberhardDepartment of Biological Chemistry, Weizmann Institute of Science, Rehovot 76100, Israel.
Arik Makovitzki
Anne Beauvais
Jean-Paul Latgé
Steffen Jung
Yechiel Shai
Institut Pasteur · FRWeizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillus fumigatus is an opportunistic fungal pathogen responsible for invasive aspergillosis in immunocompromised individuals. The inefficiency of antifungal agents and high mortality rate resulting from invasive aspergillosis remain major clinical concerns. Recently, we reported on a new family of ultrashort cationic lipopeptides active in vitro against fungi. Mode of action studies supported a membranolytic or a detergent-like effect. Here, we screened several lipopeptides in vitro for their anti-A. fumigatus activity. To investigate the therapeutic properties of the selected peptides in vivo, we challenged immunosuppressed C57BL/6 wild-type mice intranasally with DsRed-labeled A. fumigatus conidia and subsequently treated the animals locally with the lipopeptides. Confocal microscopic analysis revealed the degradation of DsRed-labeled hyphal forms and residual conidia in the lungs of the mice. The most efficient peptide was tested further using a survival assay and was found to significantly prolong the life of the treated animals, whereas no mice survived with the current standard antifungal treatment with amphotericin B. Moreover, as opposed to the drug-treated lungs, the peptide-treated lungs did not display any toxicity of the peptide. Our results highlight the potential of this family of lipopeptides for the treatment of pulmonary invasive aspergillosis.

Indexed as

Antifungal AgentsLipoproteinsPeptidesAnimalsAspergillosisAspergillus fumigatusHumansImmunocompromised HostLungLung Diseases, FungalMiceMice, Inbred C57BLMicrobial Sensitivity TestsTreatment OutcomeAntifungal AgentsLipoproteinsPeptides

Identifiers

PMID18606837
PMCPMC2533451
OpenAlexW2029135321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.